MM
ABBV icon

MQS Management’s AbbVie ABBV Stock Holding History

MQS Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,793
Closed -$390K – 256
2026
Q1 		$390K Sell
1,793
-1,150
-39% -$255K 0.26% 150
2025
Q4 		$672K Buy
+2,943
New +$670K 0.4% 60
2023
Q3 		– Sell
-2,693
Closed -$363K – 409
2023
Q2 		$363K Buy
+2,693
New +$395K 0.25% 159
2022
Q3 		– Sell
-3,015
Closed -$462K – 392
2022
Q2 		$462K Buy
+3,015
New +$461K 0.32% 116

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MQS Management's ABBV Position: Q2 2026 in Review

MQS Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,793 shares — an estimated $390K sold.

MQS Management first reported a position in ABBV in Q2 2022 and held it in 4 quarters. The position peaked at $672K in Q4 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MQS Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • MQS Management sold 1,793 AbbVie shares in Q2 2026, an estimated $390K.
  • MQS Management first reported a position in AbbVie in Q2 2022 and held it in 4 quarters.
  • MQS Management's AbbVie position peaked at $672K in Q4 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.